Corticosteroids delay remyelination of experimental demyelination in the rodent central nervous system
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
High dose corticosteroid (CS) administration is a common mode of therapy in treatment of acute relapses in multiple sclerosis (MS) but the effects of CS on remyelination and the cellular mechanisms mediating this repair process are controversial. We have examined CS effects on repair of toxin-induced demyelinating lesions in the adult rat spinal cord. Corticosteroids reduced the extent of oligodendrocyte remyelination at 1 month post lesion (whereas Schwann-cell mediated repair was unaffected). However, CS did not cause permanent impairment of remyelination as lesions were fully remyelinated at 2 months after cessation of treatment. The delay in oligodendrocyte mediated repair could be attributed to inhibition of differentiation of oligodendrocyte progenitor cells (OPCs) into oligodendrocytes, with no effect of CS treatment observed on OPC colonisation of the lesions. No differences were observed in animals treated with methylprednisolone succinate alone or with a subsequent prednisone taper indicating that CS effects occur at an early stage of repair. The potential consequences of delayed remyelination in inflammatory lesions are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
TNFα promotes proliferation of oligodendrocyte progenitors and remyelination
Arnett, H. A., Mason, J., Marino, M., Suzuki, K., Matsushima, G. K., & Ting, J. P.-Y. (2001) · Nature Neuroscience · doi:10.1038/nn738 · Cited by 1,012
Axonal Swellings and Degeneration in Mice Lacking the Major Proteolipid of Myelin
Griffiths, I., Klugmann, M., Anderson, T., Yool, D., Thomson, C., Schwab, M. H., Schneider, A., Zimmermann, F., McCulloch, M., Nadon, N., et al. (1998) · Science · doi:10.1126/science.280.5369.1610 · Cited by 889 · cited 2×
“, 1979; Jeffery and Blakemore, 1997) with increasing evidence that it may be critical for preserving axonal integrity (Griffiths et al., 1998; Kornek et al., 2000; Garbern et al., 2002; Edgar et al., 2004).”
Multiple sclerosis: Remyelination of nascent lesions: Remyelination of nascent lesions
Prineas, J. W., Barnard, R. O., Kwon, E. E., Sharer, L. R., & Cho, E. ‐. (1993) · Annals of Neurology · doi:10.1002/ana.410330203 · Cited by 574 · cited 1×
“Extensive remyelination can occur in demyelinating lesions, including many acute plaques of MS (Prineas and Connell, 1979; Prineas et al., 1993, Lassmann et al., 1997); remyelination restores function lost as a consequence of demye- lination (Smith et al., 1979; Jeffery and Blakemore, 1997) with…”
BackgroundEndogenous progenitors remyelinate demyelinated axons in the adult CNS
Gensert, J. M., & Goldman, J. E. (1997) · Neuron · doi:10.1016/s0896-6273(00)80359-1 · Cited by 544
Interleukin-1β Promotes Repair of the CNS
Mason, J. L., Suzuki, K., Chaplin, D. D., & Matsushima, G. K. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-18-07046.2001 · Cited by 502
Remyelination in multiple sclerosis
Prineas, J. W., & Connell, F. (1979) · Annals of Neurology · doi:10.1002/ana.410050105 · Cited by 454
Kotter, M. R., Setzu, A., Sim, F. J., Van Rooijen, N., & Franklin, R. J. M. (2001) · Glia · doi:10.1002/glia.1085 · Cited by 385 · cited 5×
“, 1997) including within remyelinating lesions (Hinks and Franklin, 2000; Kotter et al., 2001).”
InfluentialSelf-citationWilkins, A., Majed, H., Layfield, R., Compston, A., & Chandran, S. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-12-04967.2003 · Cited by 337 · cited 2×
“Oligodendroglia may support survival and maintenance of neurons by producing molecules like nerve growth factor and brain derived neurotrophic factor and there is evidence for OPCs/differentiated oligodendrocytes supporting neuronal survival via contact mediated/soluble mechanisms, providing a mechanism by which remye…”
Kotter, M. R., Zhao, C., van Rooijen, N., & Franklin, R. J. M. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.09.019 · Cited by 331
Self-citationEdgar, J. M., McLaughlin, M., Yool, D., Zhang, S.-C., Fowler, J. H., Montague, P., Barrie, J. A., McCulloch, M. C., Duncan, I. D., Garbern, J., et al. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200312012 · Cited by 328 · cited 2×
“, 1979; Jeffery and Blakemore, 1997) with increasing evidence that it may be critical for preserving axonal integrity (Griffiths et al., 1998; Kornek et al., 2000; Garbern et al., 2002; Edgar et al., 2004).”
Multiple Sclerosis: Remyelination in Acute Lesions
Raine, C. S., & WU, E. (1993) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199305000-00003 · Cited by 285
Differentiation of proliferated NG2-positive glial progenitor cells in a remyelinating lesion
Watanabe, M., Toyama, Y., & Nishiyama, A. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10338 · Cited by 261 · cited 9×
“Additionally, to determine if OPC densities were affected after CS administration in normal white matter (WM), a 1-mm square graticule was randomly superimposed over the lateral funiculi under a 340 objective lens and densities of PDGFRa-positive cells were estimated and expressed as numbers of cells/mm2.”
InfluentialEfficient central nervous system remyelination requires T cells
Bieber, A. J., Kerr, S., & Rodriguez, M. (2003) · Annals of Neurology · doi:10.1002/ana.10578 · Cited by 196 · cited 2×
“…studies demonstrating an impairment of remyelination in the absence of lymphocytes, MHC Class II antigens, inflammatory cytokines, macrophages, and inhibition of microglial activation (Arnett et al., 2001, 2003; Mason et al., 2001; Kotter et al., 2001, 2005; Bieber et al., 2003; Li et al., 2005).”
Remyelination in multiple sclerosis
Lassmann, H., Brück, W., Lucchinetti, C., & Rodriguez, M. (1997) · Multiple Sclerosis Journal · doi:10.1177/135245859700300213 · Cited by 191 · cited 1×
“Extensive remyelination can occur in demyelinating lesions, including many acute plaques of MS (Prineas and Connell, 1979; Prineas et al., 1993, Lassmann et al., 1997); remyelination restores function lost as a consequence of demye- lination (Smith et al., 1979; Jeffery and Blakemore, 1997) with…”
BackgroundArnett, H. A., Wang, Y., Matsushima, G. K., Suzuki, K., & Ting, J. P.-Y. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-30-09824.2003 · Cited by 190
Zhao, C., Li, W.-W., & Franklin, R. J. M. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.06.008 · Cited by 142 · cited 2×
“The PLP/ DM20 probe was generated from mouse PLP/DM20 cDNA (a gift from I.R. Griffiths, Glasgow, UK), subcloned into the pGEM plasmid (Promega, Southampton, UK).”
Self-citationEarly glial responses in murine models of multiple sclerosis
Ayers, M. M., Hazelwood, L. J., Catmull, D. V., Wang, D., McKormack, Q., Bernard, C. C. A., & Orian, J. M. (2004) · Neurochemistry International · doi:10.1016/j.neuint.2003.08.018 · Cited by 51 · cited 2×
“Reactive astrocytosis, generally evaluated by GFAP immunoreactivity, is an early response during demyelination (Ayers et al., 2004) and accompanies inflammatory changes in MS lesions (Hemmer et al.”
Cited by
Remyelination in the CNS: from biology to therapy
Franklin, R. J. M., & ffrench-Constant, C. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2480 · Cited by 1,544
Self-citationKuhlmann, T., Miron, V., Cuo, Q., Wegner, C., Antel, J., & Bruck, W. (2008) · Brain · doi:10.1093/brain/awn096 · Cited by 864
Impaired adult myelination in the prefrontal cortex of socially isolated mice
Liu, J., Dietz, K., DeLoyht, J. M., Pedre, X., Kelkar, D., Kaur, J., Vialou, V., Lobo, M. K., Dietz, D. M., Nestler, E. J., et al. (2012) · Nature Neuroscience · doi:10.1038/nn.3263 · Cited by 685
Neuregulin-ERBB Signaling in the Nervous System and Neuropsychiatric Diseases
Mei, L., & Nave, K.-A. (2014) · Neuron · doi:10.1016/j.neuron.2014.06.007 · Cited by 592
Remyelination capacity of the MS brain decreases with disease chronicity
Goldschmidt, T., Antel, J., König, F. B., Brück, W., & Kuhlmann, T. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a8260a · Cited by 411
Metadata
- Authors
- Chari, D. M., Zhao, C., Kotter, M. R., Blakemore, W. F., & Franklin, R. J. M.
- Venue
- Journal of Neuroscience Research
- Publisher
- Wiley
- Published
- 2006
- Volume
- 83
- Issue
- 4
- Pages
- 594-605
- ISSN
- 0360-4012 (ISSN-L)
- 1097-4547
- OpenAlex
- W2021440042
- Cited by
- 66
- References
- 17
- FWCI
- 4.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.